Herantis Pharma logo
Search
  • About Us
    • Company Profile
    • Management Team
    • Board of Directors
    • Nomination Committee
    • Scientific Advisory Board
  • Research & Development
    • Lead asset HER-096
    • CDNF protein
    • Focus area: Parkinson’s disease
    • Scientific Publications
  • Investors
    • Company Presentation
    • Stock Exchange & Press Releases
    • Share and Shareholders
      • Share Information
      • Certified Advisor
      • Major Shareholders
      • Share Monitor
      • Top Manager Transaction History
    • Financial Reports
    • Financial Calendar
    • Analyst Coverage
    • General Meetings
    • Articles of Association
    • Corporate Governance
    • Investor Relations
    • Subscription Service
  • News & Events
    • Events
    • Releases
    • Public Materials
    • Company Live Presentations
  • Contact
  • FIN
Search
  • About Us
    • Company Profile
    • Management Team
    • Board of Directors
    • Nomination Committee
    • Scientific Advisory Board
  • Research & Development
    • Lead asset HER-096
    • CDNF protein
    • Focus area: Parkinson’s disease
    • Scientific Publications
  • Investors
    • Company Presentation
    • Stock Exchange & Press Releases
    • Share and Shareholders
      • Share Information
      • Certified Advisor
      • Major Shareholders
      • Share Monitor
      • Top Manager Transaction History
    • Financial Reports
    • Financial Calendar
    • Analyst Coverage
    • General Meetings
    • Articles of Association
    • Corporate Governance
    • Investor Relations
    • Subscription Service
  • News & Events
    • Events
    • Releases
    • Public Materials
    • Company Live Presentations
  • Contact
  • FIN

Latest releases

  • CDNF releases
  • Earnings Release
  • First north
  • General releases
  • Insider trading
  • Press Release
  • Clear
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 20.01.2023
    FN, GR
    Proposals of the Shareholders’ Nomination Committee to Herantis Pharma Plc’s Annual General Meeting 2023
  • 19.01.2023
    PR
    Herantis Pharma: Key takeaways from todays R&D update webinar
  • 12.01.2023
    GR, PR
    Herantis Pharma to host a R&D update webinar on January 19, 2023
  • 04.01.2023
    PR
    Herantis Pharma to participate in Biotech Showcase and Sachs virtual conferences
  • 22.12.2022
    GR, IT
    Herantis Pharma Oyj: Managers’ Transactions – Antti Vuolanto
  • 22.12.2022
    GR, IT
    Herantis Pharma Oyj: Managers’ Transactions – Tone Kvåle
  • 22.12.2022
    GR, IT
    Herantis Pharma Oyj: Managers’ Transactions – Henri Huttunen
  • 20.12.2022
    PR
    Herantis Pharma to host a R&D update webinar January 19, 2023
  • 19.12.2022
    FN, GR
    Herantis Pharma selected for European Innovation Council (EIC) grant of €2.5 million
  • 19.12.2022
    PR
    Herantis Pharma announces submission of a Clinical Trial Application (CTA) for a Phase 1 study for HER-096
  • « Previous page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • ...
  • Page 22
  • Next page »

Quick links

Events »
Releases »
Public Materials »
Company Live Presentations »
Herantis Pharma logo

HERANTIS PHARMA Plc
Bertel Jungin Aukio 1
FIN-02600 Espoo

Tel: +358 9 222 1195
Email: info (at) herantis.com
VAT number FI21986657

  • Legal notice
  • Privacy notice
  • Sign up for our bi-monthly newsletter
  • Cookie settings

Copyright © HERANTIS PHARMA Plc. All rights reserved.

Cookies
This website uses cookies and Google Analytics. We use cookies and Google Analytics to adapt the website according to your preferences and to collect information about the use of the website. For more information regarding cookies we request you to review our privacy notice. The following terms and conditions are applied to the use of this website. By continuing to use this website you accept such terms and conditions.
Accept all
Cookie settings
Privacy notice
Legal notice
Cookie settings

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
CookieDurationDescription
_GRECAPTCHAsessionProvides SPAM protection on web forms.
cookielawinfo-checkbox-analytics1 yearThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-necessary1 yearThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
CookieLawInfoConsent1 yearRecords the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
viewed_cookie_policy1 yearThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
wp-wpml_current_language1 dayRecords the user language selection used be the WPML tool.
Analytics cookies
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsCounts and stores user data, clicks, pageviews etc. for Google Analytics
_ga_RCZB8QBE9K2 yearsCounts and stores user data, clicks, pageviews etc. for Google Analytics
_gat_gtag_UA_50874989_11 minuteUsed for to limit http requests on Google Marketing platform (doubleclick.net). Doesn't store any user data.
_gid1 dayStores an unique ID that is used for generating user-specific statistics in Google Analytics
SAVE & ACCEPT